| Metric | Q1 2021 | Q4 2020 | Q1 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $10.1B | — | — | — | — |
| Op. Income | $1.9B | — | — | — | — |
| Gross Margin | 82.6% | — | — | — | — |
| Net Margin | 11.6% | — | — | — | — |
| EPS (Diluted) | $0.55 | — | — | — | — |
| Free Cash Flow | $0 | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $10.1B |
| Cost of Revenue | $1.8B |
| GROSS PROFIT | $8.3B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $6.4B |
| SG&A Expenses | $6.4B |
| Other Expenses | $54M |
| Operating Expenses | $6.5B |
| Cost & Expenses | $8.2B |
| OPERATING INCOME | $1.9B |
| Interest Income | $5.0B |
| Interest Expense | $1.7B |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $1.9B |
| Income Tax Expense | $645M |
| Net Income from Continuing Ops | $1.2B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $1M |
| NET INCOME | $1.2B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $1.1B |
| D&A | $0 |
| EBIT | $1.9B |
| EBITDA | $1.9B |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $10.1B |
| Cost of Revenue | $1.8B |
| GROSS PROFIT | $8.3B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $6.4B |
| SG&A Expenses | $6.4B |
| Other Expenses | $54M |
| Operating Expenses | $6.5B |
| Cost & Expenses | $8.2B |
| OPERATING INCOME | $1.9B |
| Interest Income | $5.0B |
| Interest Expense | $1.7B |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $1.9B |
| Income Tax Expense | $645M |
| Net Income from Continuing Ops | $1.2B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $1M |
| NET INCOME | $1.2B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $1.1B |
| D&A | $0 |
| EBIT | $1.9B |
| EBITDA | $1.9B |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $1.2B |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$1.2B |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $0 |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $0 |
| FREE CASH FLOW | $0 |
| Net Change in Cash | $0 |
| Item | Amount |
|---|---|
| Cash & Equivalents | $224.2B |
| Short-Term Investments | $48.7B |
| Net Receivables | $1.1B |
| Inventory | $0 |
| Other Current Assets | $974.9B |
| TOTAL CURRENT ASSETS | $1.2T |
| PP&E (Net) | $6.4B |
| Goodwill | $0 |
| Intangible Assets | $8.0B |
| Long-Term Investments | $276.9B |
| Tax Assets | -$8.0B |
| Other Non-Current Assets | $8.0B |
| TOTAL NON-CURRENT ASSETS | $291.3B |
| TOTAL ASSETS | $1.5T |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$913M |
| TOTAL CURRENT LIABILITIES | $5.5B |
| Long-Term Debt | $174.6B |
| Deferred Revenue NC | -$602.5B |
| Deferred Tax Liabilities | $655M |
| Other Non-Current Liabilities | -$175.2B |
| TOTAL NON-CURRENT LIABILITIES | $175.2B |
| TOTAL LIABILITIES | $1.5T |
| Common Stock | $6.2B |
| Additional Paid-In Capital | $47.2B |
| Retained Earnings | $13.2B |
| Treasury Stock | -$41M |
| Accum. Other Comp. Income | -$810M |
| Other Equity | $6.8B |
| TOTAL STOCKHOLDERS' EQUITY | $72.6B |
| Minority Interest | $1.9B |
| TOTAL EQUITY | $74.5B |
| TOTAL LIABILITIES & EQUITY | $1.5T |
| Total Debt | $180.1B |
| Net Debt | -$44.1B |
